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Based on the predicted capacity to interact with membranes at the interface, we have found three regions in the ectodomain of the hepatitis C
virus envelope glycoprotein E2 (430–449, 543–560 and 603–624) with the ability to destabilize membranes. Three peptides corresponding to the
sequence of these regions have been synthesized and their interaction with liposomes have been characterized. The three peptides were able to
insert deeply into the hydrophobic core of negatively charged phospholipids as stated by fluorescence depolarization of the probe 1,6-diphenyl-
1,3,5-hexatriene. Peptides E2430–449 and E2603–624 were able to induce aggregation of phosphatidylglycerol vesicles in a concentration-dependent
manner both at neutral and acidic pH while peptide E2543–560 did not induce any increase of optical density at 360 nm in the concentration range
studied. The three peptides induced lipid mixing and the release of the internal contents in a dose-dependent manner when acidic phospholipids
were used. Fourier transformed infrared spectroscopy indicated that the peptides adopted mainly a β-sheet conformation which is not modified by
the presence of acidic phospholipids. Taken together, our results point out to the involvement of these three regions in the fusion mechanism of
HCV at the plasma membrane level.
© 2006 Elsevier B.V. All rights reserved.1. Introduction
Hepatitis C virus (HCV) is themajor causative agent of non-A,
non-B viral hepatitis throughout the world [1]. HCV is a positive-
stranded RNAvirus which belongs to the Flaviviridae family [2].
The HCV genomic RNA contains a long open reading frame
(ORF) that encodes a polyprotein that is proteolytically cleaved
by viral and cellular proteases to generate the structural (C, E1, E2
and p7) and non-structural (NS2, NS3, NS4A, NS4B, NS5A and
NS5B) proteins [3]. Recently, additional proteins, synthesized by
ribosomal frameshift from a coding sequence that overlaps the
core protein reading frame, have been reported [4].
The mechanism of HCVattachment and entry into target cells
is not known. Although some cell lines exhibit limited replication
of HCV [5,6], studies of the infection mechanisms of HCV have⁎ Corresponding author. Tel.: +34 913944266; fax: +34 913944159.
E-mail address: pacog@bbm1.ucm.es (F. Gavilanes).
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doi:10.1016/j.bbamem.2006.04.024been hampered by the lack of an efficient, reliable cell culture
system that support the full replication of HCV.
HCV envelope proteins E1 and E2 (residues 192–383 and
384–746 of the polyprotein, respectively) are type I transmem-
brane proteins, highly glycosylated, consisting of a large N-
terminal ectodomain and a C-terminal hydrophobic anchor that
retains them in the endoplasmic reticulum [7]. The extracellular
domains of E1 and E2 are thought to play an important role in the
interaction between the virus and its receptor as well as in the
fusion of the viral and cellular membranes. To date, the iden-
tification of the cellular receptor for HCV remains elusive and
controversial. Among others, human CD81, a member of the
tetraspanin superfamily [8,9], the low-density lipoprotein receptor
(LDL-r) [10], the human scavenger receptor class B type I [11]
and the C-type lectins DC-SIGN/DC-SIGNR [12] have been
reported as receptors for the HCV.
Entry of an envelope virus in a host cell requires not only its
binding to one or more receptors in the cell surface but also the
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at the cell plasma membrane, mediated by the interaction of the
viral envelope proteins and their receptors in a pH-independent
manner, or in the endosomal compartment, at acidic pH, after
uptake of the virus by receptor-mediated endocytosis [13].
The majority of the viral fusion proteins that have been studied
can be divided into two classes. Class I includes the fusion
proteins of ortomyxo-, retro-, paramyxo-, and filoviruses, all of
which are activated by proteolytic cleavage [14]. In these proteins,
the fusion peptide is just C-terminal to the cleavage point in the
precursor and becomes – or is near to – the N terminus of the
mature fusion protein. Class II includes the fusion proteins of
flaviviruses and alphaviruses and possesses internal fusion pep-
tides that are not proteolytically cleaved duringmaturation but are
associated with a second protein whose cleavage is essential for
activation of fusion activity [15].
Available data concerning the fusion step of HCVare scarce.
However, some studies suggest that the entry of HCV into the
host cell takes place through the endosome at acidic pH. Thus,
the cell fusion activity of HCV envelope proteins have been
studied using a CHO cell line constitutively expressing HCV
envelope proteins E1 and E2 on the cell surface [16]. This study
demonstrated the requirement for both chimeric E1 and E2
proteins and the increase of the fusion activity of HCVenvelope
proteins by the low pH treatment. On the other hand, the entry of
pseudotyped vesicular stomatitis virus (VSV) possessing E1 or
E2 into the cell is inhibited by lysosomotropic bases or inhibitors
of vacuolar H+ ATPases [17]. However, up to date, no sequence
of the HCVenvelope proteins has been reported to be implicated
in the fusion process.
In the present work, we show the existence of three internal
sequences in the ectodomain of E2, based on the hydrophobicity
scale of Wimley and White [18], which have destabilizing
effects inmembranemodel systems and, hence, could participate
in the fusion of the viral and cellular membranes.
2. Methods
2.1. Reagents
N-(7-nitro-2,1,3-benzoxadiazol-4-yl)dimyristoylphosphatidylethanolamine
(NBD-PE), N-(lissamine rhodamine B sulfonyl)-diacylphosphatidylethanola-
mine (Rh-PE), egg phosphatidylcholine (PC), egg phosphatidylglycerol (PG),
and dimyristoylphosphatidylglycerol (DMPG) were provided by Avanti Polar
Lipids. 8-Aminonaphtalene-1,3,6-trisulfonic acid (ANTS), p-xylenebis(pyridi-
nium) bromide (DPX) and 1,6-diphenyl-1,3,5-hexatriene (DPH) were purchased
from Molecular Probes. Triton X-100 was purchased from Boehringer Mann-
heim. All other reagents were obtained from Merck and Sigma. All solvents
were of HPLC grade.
2.2. Peptide synthesis
Peptides were synthesized as the C-terminal amide on an automated multiple
peptide synthesizer (AMS 422, Abimed) using previously described procedures
[19] by the solid-phase procedure and standard Fmoc chemistry in a base of 25
μmol. Briefly, the synthesis was carried out on aN-α-Fmoc-DMP resin [4-(2′,4′-
dimethoxyphenil-Fmoc-aminomethyl)phenoxy resin (Novabiochem)] with
Fmoc-protected amino acids activated in situ with PyBOC (benzotriazole-1-
yl-oxy-tris-pyrrolidinophosphonium hexafluorophosphate) in the presence of N-
methylmorpholine and 20% piperidine/dimethylformamide for deprotection.The protecting side chains were as follows: Asn, Gln andHis (Trt), Arg (pmc), Asp
(OtBu), Cys (Acm), Lys (Boc), Ser, Thr and Tyr (tBu). Peptides were purified by
reverse-phase HPLC using an Ultrasphere-ODS C18 column (10×150 mm) with a
linear gradient (0–35%) of acetonitrile in 0.1% trifluoroacetic acid. Due to the low
solubility of the peptides in aqueous buffers, a 10 mg/ml stock solution in dime-
thylsulfoxide (DMSO) was kept perfectly sealed at −20 °C and employed in the
various assays described in this work. The final organic solvent concentration was
always kept under 2% (v/v) and had no measurable effect on vesicle stability. The
peptide concentration of the stock solutionswas determined by amino acid analysis
which was performed on a Beckman 6300 amino acid analyzer.
2.3. Vesicle preparation
In all cases, a lipid film was obtained by drying a cloroform:methanol (2:1)
solution of the lipid under a current of nitrogen and this filmwas further kept under
vacuum for 4–5 h to completely remove the organic solvent. The phospholipids
were resuspended at a concentration of 1 mg/ml in medium buffer (100 mMNaCl,
5 mMMES, 5 mM sodium citrate, 5 mMTris, 1 mMEDTA) at the appropriate pH
value and incubated for 1 h at 37 °C and eventually vigorously vortexed. This
suspensionwas sonicated in a bath sonicator (Branson 1200) andwas subsequently
subjected to fifteen cycles of extrusion in a Liposo Fast-Basic extruder apparatus
(Avestin, Inc.) with 100-nm polycarbonate filters (Costar). When encapsulation
was required, an additional step of five freeze–thawing cycles was included after
the sonication process.
2.4. Vesicle aggregation
The increase in the optical density at 360 nm (ΔOD360) produced by addition of
the peptide from a concentrated stock solution in DMSO to a phospholipid vesicle
suspension, in medium buffer at the appropriated pH, wasmeasured on a Beckman
DU-7 spectrophotometer after incubation for 1 h at 37 °C. Values of control
samples containing corresponding amounts of peptide dissolved in DMSO were
subtracted at each peptide concentration. The final phospholipid concentrationwas
0.13 mM.
2.5. Release of aqueous contents
Leakage was determined by the ANTS/DPX assay [20], which is based on the
dequenching of ANTS fluorescence caused by its dilution upon release of the
aqueous contents of one vesicle preparation containing both ANTS and DPX. It
was performed by coencapsulating 12.5 mM ANTS and 45 mM DPX in 10 mM
Tris, 20mMNaCl, pH 7.2, in phospholipid vesicles. The lipid filmwas hydrated as
described previously, and the vesicles were sonicated 30 min. Afterwards, the
vesicles were subjected to five cycles of freeze–thawing in liquid nitrogen an
passed 15 times through an extruder apparatus (Avestin, Inc.) with 100-nm poly-
carbonate filters (Costar). After the vesicles with the coencapsulated probe and
quencher were formed, the whole sample was passed through a Sephadex G-75
column (Pharmacia) to separate the vesicles from the non encapsulated material
using medium buffer for elution [21]. The final phospholipid concentration in the
assaywas 0.13mMandmedium buffer at the appropriated pH value was used in all
cases. After adding the peptide from a DMSO stock solution, the samples were
incubated for 1 h at 37 °C and measured in a SLM Aminco 8000 C spectro-
fluorimeter. The organic solvent had no measurable effect on vesicle stability. The
excitation wavelengthwas set at 385 nm, and theANTS emissionwasmonitored at
520 nm. Both the excitation and emission slits were set at 4 mm. The excitation and
emission polarizers were kept constant at 90° and 0°, respectively, to minimize
interference due to dispersion. The fluorescence scale was set to 100% by addition
of 0.5%Triton X-100, and 0% leakage was obtainedmeasuring the fluorescence of
control vesicles without peptide.
2.6. Lipid mixing assay
Lipid mixing was monitored by using the classical fluorescent probe dilution
assay [22], in which the decrease in the efficiency of the fluorescence energy
transfer between NBD-PE (energy donor) and Rh-PE (energy acceptor) incor-
porated into liposomes, as a consequence of lipidmixing, ismonitored. Liposomes,
in medium buffer at the appropriated pH, labeled with 1 mol%NBD-PE and 1 mol
Fig. 1. (A) Hydrophobicity plot of E1 and E2 proteins. The scales of Wimley and
White (black line) and Kyte and Doolittle (grey line) were used. The sequences
of E1 and E2 correspond to residues 192–383 and 384–746 of the polypro-
tein, respectively. A 19-amino-acid window was employed and the average
value was assigned to residue 10th. (B) Amino acid sequence of the three E2
peptides.
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was initiated by addition of the peptide from a stock solution in DMSO. The
samples were incubated for 1 h at 37 °C, and the emission spectra were recorded
with the excitationwavelength set at 450 nm. Both the excitation and emission slits
were set at 4 mm. The excitation polarizer was kept constant at 90°, and the
emission polarizer was kept constant at 0° tominimize dispersive interference. The
efficiency of the energy transfer was calculated from the ratio of the emission
intensities at 530 and 590 nm and the appropriated calibration curve. The final
phospholipid concentration was 0.13 mM. The organic solvent itself had no effect
on the efficiency of the energy transfer.
2.7. Fluorescence polarization
Fluorescence polarization measurements of 1,6-diphenyl-1,3,5-hexatriene
(DPH) were taken by using 10 mm Glan-Thompson polarizers. DMPG vesicles
(0.13 mM) were prepared as indicated above containing the probe DPH at a
weight ratio of 1:500. The peptide was added from a stock concentrated solution
in DMSO. Peptide-vesicle mixtures were incubated for 1 h at 37 °C and then
cooled. The excitation was set at 365 nm and emission was measured at 425 nm,
after equilibration of the samples at the indicated temperature. The temperature
in the cuvette was maintained with a circulating water bath.
2.8. Fourier transformed infrared spectroscopy
Lyophilized aliquots of peptides (300 μg) were dissolved in 50 μl of deuterated
medium buffer, pD 5.4, to avoid the interference of H2O infrared absorbance
(1645 cm−1) on the protein amide I band [23]. Infrared spectra were acquired on an
IFS 66/S instrument (Bruker) equipped with a DTGS detector. Usually, 600 scans/
sample were taken, averaged, apodized with a Happ-Genzel function and Fourier
transformed to give a nominal resolution of 2 cm−1. Fourier self-deconvolutionwas
performed using a Lorenztian bandwidth of 18 cm−1 and a resolution enhancement
factor of 2 [24,25]. Peptide secondary structure was quantified by band decon-
volution of the amide I band. The number and position (wavenumber) of the bands
were taken from the deconvoluted spectra. The iterative curve-fitting process was
performed in CURVEFIT running under SpectraCalc (Galactic Industries Corp.).
The number, position, and band shapewere fixed during the first 200 iterations. The
fitting was further refined by allowing the band positions to vary for 50 additional
iterations. The goodness of the fit was assessed from the χ2 values (4×10−5 to
6.5×10−5). The area of the fitted band was used to calculate the percentage of
secondary structure [24–26].
3. Results
3.1. Putative fusion peptides of HCV
Based on the water-to-membrane interface transfer free ener-
gies for each amino acid, Wimley and White have elaborated a
whole-residue hydrophobicity scale compiling the energetic
components that dictate initial partitioning of unfolded peptide
sequences intomembranes [18]. This scale has been applied to the
detection of membrane-partitioning regions within the ectodo-
mains of several viral fusion proteins [27,28]. Fig. 1 shows a
combined representation of the hydrophobicity plots of Wimley–
White and Kyte–Doolittle [29] of E1 and E2 proteins. Both plots
identified a stretch in the C-terminal region of both E1 and E2
with a high hydrophobic index that corresponds to the proposed
transmembrane domains of the envelope proteins. In the ecto-
domain of E1, both profiles identified a broad highly hydrophobic
region (residues 265–295) which could also constitute a trans-
membrane region. The interfacial hydrophobicity plot revealed
three regions in the ectodomain of E2 (residues 430–449, 543–
560 and 603–624) with capacity to destabilize membranes, due to
its high tendency to interact with membranes at the interface.Moreover, the regions 543–560 and 603–624 are immediately
followed by stretches identified as hydrophobic in the scale of
Kyte–Doolittle and, thus, can interact with internal regions in the
lipid bilayer. It has been described that a sequence with the ability
to interact with the lipid interface immediately followed by a
transmembrane region can constitute a new structural motif
implicated in viral fusion [27,28]. Finally, the Kyte–Doolittle plot
revealed two hydrophobic regions in E2 (N-terminal and residues
497–515) not detected in the Wimley–White plot. These regions
are not predicted to interact with lipid bilayers at the interface
and thus to destabilize membranes, although their interaction
with the internal region of the bilayer is not discarded. Hence,
the three interfacial regions detected in the ectodomain of E2
are the best candidates to act as fusion peptides of HCV. Thus,
peptides corresponding to these regions were chemically syn-
thesized. Their amino acid sequences are shown in Fig. 1B. All
three peptides were purified by HPLC, yielding preparations
with purity higher than 95%. Their amino acid composition
correlates perfectly with that expected from their amino acid
sequence. MALDI-TOF mass spectrometry yielded the follow-
ing results: peptide E2430–449, m/z 2370.3 (calculated 2370.6);
peptide E2543–560, m/z 2071.0 (calculated 2071.3); peptide
E2603–624, m/z 2786.3 (calculated 2786.2).
3.2. Vesicle aggregation
The ability of the peptides to induce vesicle aggregation was
monitored by measuring the increment in the optical density at
Fig. 2. Aggregation of PC and PG phospholipids vesicles induced by E2 peptides. The optical density at 360 nm (ΔOD360) was measured after incubation of vesicles in
medium buffer at pH 7.5 (●) and 5.0 (o) with aliquots of peptide from a stock solution in DMSO. The concentration of DMSOwas kept below 1%. The results shown
are representative of those obtained for at least three different experiments.
Fig. 3. Leakage of ANTS/DPX from PG vesicles induced by E2 peptides.
Increasing concentrations of E2 peptideswere added to vesicles loadedwith ANTS
andDPX inmedium buffer at pH 7.5 (●) and 5.0 (o).The concentration of DMSO
was kept below 1% and had no measurable effect on vesicle stability. The results
shown are representative of those obtained for at least three different experiments.
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increase in vesicle size. As shown in Fig. 2, peptides E2430–449
and E2603–624 were able to induce aggregation of neutral and
acidic phospholipid vesicles in a concentration-dependentmanner
both at neutral and acidic pHs. The OD360 values reached with
E2430–449 peptide and either PC or PG are around 3 times higher at
pH 5.0 than at pH 7.5. Thiswas also the case for peptide E2603–624
which induced an increase in the OD360 of PG vesicles 5 times
higher at pH 5.0 than at pH 7.5. Moreover, the increase in OD360
induced by the peptide E2603–624 at pH 5.0 was 3 times higher
than that observed with the peptide E2430–449. When neutral
phospholipids were employed E2603–624 almost did not induce
any vesicle aggregation at pH 5.0 (Fig. 2). On the other hand,
peptide E2543–560 did not induce any increase of the optical
density at 360 nm of either neutral or acidic phospholipids in the
concentration range studied (data not shown).
3.3. Release of aqueous contents
The ability of these peptides to destabilize the lipid bilayer was
assessed by measuring the release of aqueous contents of phos-
pholipid vesicles. Liposome leakage was followed by measuring
the increase in ANTS fluorescence at 520 nm [20]. Fig. 3 shows
the leakage induced by the synthetic peptides added to PG
vesicles. Either peptide was able to induce the release of the
internal contents of the liposomes in a dose-dependent manner.
The peptide concentrations needed to attain the maximum effect
were substantially lower than those needed to induce vesicle
aggregation (Fig. 2).
Peptide E2430–449 induced release of aqueous contents at acidic
pH reaching 100% at a peptide/lipid molar ratio of 0.05 (6.5 μM
peptide), while at the same ratio and neutral pH leakage was very
low, 10%, being necessary a peptide concentration 4-fold higher to
attain 100%of leakage. Although peptide E2543–560 did not induce
vesicle aggregation, it was able to destabilize the membrane
leading to the release of the aqueous content at relatively low
Fig. 4. Lipid mixing induced by E2 peptides. Increasing concentrations of the E2
peptides were added to a 1:9 mixture of labeled (NBD-PE 1% and Rh-PE 1%)
and unlabeled PG vesicles hydrated in medium buffer at pH 7.5 (●) and 5.0 (o).
The concentration of DMSO was kept below 1%. The results shown are
representative of those obtained for three different experiments.
Fig. 5. Temperature dependence of fluorescence polarization of DPH-labeled DMPG
(E2430–449), 0.175 (E2543–560) and 0.203 (E2603–624) and (▼) 0.515 (E2430–449), 0.433
obtained for three different experiments.
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pH, and 90% leakage was reached at a peptide/lipid molar ratio of
0.1 (13 μM peptide) at both pHs. Finally, E2603–624 peptide
reached 100% leakage at a peptide/lipid molar ratio as low as 0.04
(about 5 μM peptide concentration), at which no vesicle
aggregation was observed (Fig. 2). The effect of pH on breaking
the integrity of the vesicles by peptide E2603–624 was low, showing
slightly higher values at pH 7.5 than at pH 5.0.
Neither peptide destabilized the bilayer of phospholipid
vesicles composed of pure PC (data not shown).
3.4. Lipid mixing
Mixing of membrane lipids was followed by the resonance
energy transfer (RET) assay between the fluorescence probes
NBD-PE and Rh-PE [22]. In this assay, mixing of phospholi-
pids from labeled and unlabeled liposomes results in an increase
in the distance between the donor (NBD) and the acceptor (Rh),
with the concomitant decrease in energy transfer which reflects
accurately the degree of fusion [30].
Either peptide was able to induce lipid mixing of PG vesicles,
showing a similar dependence with pH to that observed for
leakage, although the peptide/lipid molar ratios needed to reach
maximum values were higher (Fig. 4).
E2430–449 peptide induced 100% lipidmixing of PG vesicles at
pH 5.0 at a peptide/lipid molar ratio of about 0.45 (58 μM
peptide), and at pH 7.5 and the same ratio this percentage was
much lower attaining only a 20% of energy transfer. E2543–560
peptide was able to induce lipid mixing in a virtually pH-
independent manner, reaching a complete lipid mixing at a
peptide/lipid molar ratio of 0.2 (26 μM peptide). Finally, lipid
mixing induced by peptide E2603–624 was independent of pHup to
peptide/lipid molar ratios of 0.2. Above this ratio, the percentageliposomes. The peptide/lipid molar ratios employed were (●) 0.0, (■) 0.206
(E2543–560) and 0.506 (E2603–624). The results shown are representative of those
Fig. 6. Amide I infrared band of the original and deconvolved spectra of the E2
peptides. Aliquots of peptides (300 μg) were dissolved in 50 μl of deuterated
medium buffer, pD 5.4.
Table 1
Secondary structure of E2 peptides in medium buffer
% a E2430–449 E2543–560 E2603–624
Helix 16 10 18
Sheet 48 53 38
Turn 29 29 32
Non-ordered 7 8 12
a The percentages were determined by deconvolution of the amide I band. The
number and position (wavenumber) of the bands were taken from the deconvolved
spectra. The area of the fitted band was used to calculate the percentage of
secondary structure.
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5.0, it continued increasing, attaining 100% at a peptide/lipid
molar ratio of 0.45.
As it occurs with the release of aqueous contents neither
peptide induced mixing of lipids of vesicles composed of pure
PC (data not shown).
3.5. Peptide insertion into phospholipid bilayers
The effect of these peptides on the thermotropic behavior of
dimyristoylphosphatidylglycerol (DMPG) vesicles has been
studied. We have measured the fluorescence polarization of
DMPG vesicles labeled in the hydrophobic core of the bilayer
with the fluorescent probe DPH at increasing temperatures.
The results obtained in the absence and the presence of
peptides at different peptide/phospholipid molar ratios at pH
7.5 and 5.0 are depicted in Fig. 5. The addition of the peptides
to DMPG vesicles induced a decrease in the amplitude of the
transition in a concentration-dependent manner. At a peptide/
lipid molar ratio of around 0.5 (65 μM peptide), either peptide
almost completely abolished the phase transition, affecting
mainly the polarization values above the transition tempera-
ture, indicating that the peptides affect mainly the acyl chains
in the liquid–crystal phase, inducing a higher order in the chain
packing. The interaction of peptide E2543–560 with phospho-
lipids caused a slight increase in the transition temperature
from 22.5 °C to 24.8 °C. Peptide E2603–624 reduced the
enthalpy of the phase transition as a consequence of the
decrease of the fluorescence polarization in the gel phase aswell as an increase in the fluorescence polarization in the liquid
crystal phase. The results were similar at both pH 7.5 and 5.0.
3.6. FTIR spectroscopy
The conformation adopted by the peptides both in the absence
and in the presence of lipids was monitored by Fourier trans-
formed infrared spectroscopy (FTIR). Fig. 6 shows the confor-
mation sensitive amide I region of the infrared spectrum of the
peptides alone in D2O medium buffer at pD 5.4. Similar results
were obtained at pD 7.5. The spectrum of E2430–449 and E2543–560
peptides exhibited a maximum centered around 1620 cm−1 while
the spectrum of the peptide E2603–624 was different with a broad
maximum centered at 1640 cm−1. Band-narrowing deconvolution
of the amide I band (Fig. 6) shows that E2430–449 and E2543–560
possess a maximum at 1618–1621 cm−1, characteristic of aggre-
gates with a β-sheet conformation, and that E2603–624 possesses,
besides amaximum at 1612 cm−1, twomaxima centered at around
1641 cm−1 and 1649 cm−1 that can be assigned to non-ordered
structures and α-helix, respectively. Fig. 6 shows that the amide I
region exhibited other maxima that can be assigned to vibration of
the carbonyl groups in peptide bonds within different secondary
structural motifs. The components between 1618 cm−1 and
1633 cm−1 are assigned to β-structures, those around 1648–
1652 cm−1 to α-helix, those between 1659 and 1690 cm−1 to
β-turns and the components in the region around 1580 and
1605 cm−1 are assigned to side chains [31].
The original infrared spectra can be fitted with the bands
obtained in the deconvolution of the spectra, which allows the
amide band I to be adjusted to the different components (data
not shown). The percentages of secondary structures calculated
from the area of the fitted bands are represented in Table 1. As
reflected in the table, the three peptides adopted mainly an ex-
tended β-structure, although the percentage of this structure was
higher for peptides E2430–449 and E2543–560 than for E2603–624
peptide which exhibited a slightly higher helical content.
The interaction with acidic phospholipids did not induce
important changes in the shape of spectra nor in the position of
the maxima, and thus, in the conformation of the peptides (data
not shown).
4. Discussion
The knowledge of the HCV viral life cycle is scarce, and the
sequence(s) involved in the fusion step have not yet been identified.
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in its sequence of a putative fusion peptide [32]. However, and
based on homology studies, E2 has also been proposed as the
protein responsible of the fusion step [33]. In the present study,
we have scanned the sequence of the HCV envelope proteins
searching for regions able to interact with lipid bilayers and thus
to participate in the fusion process. The use of the interfacial
hydrophobicity scale of Wimley and White has allowed us to
identify three regions within the ectodomain of E2 with the
ability to interact with membranes at the interface. In spite of the
limitations of the use of peptides to study the fusion step between
the viral and cellular membranes, the research on the fusogenic
properties of synthetic peptides representing a protein stretch able
to interact and destabilize a lipid bilayer has allowed the char-
acterization of the initial steps of several viral infection processes
[34].
The results obtained in this work show that synthetic peptides
corresponding to these three interfacial regions identified in the
ectodomain of E2 may interact with lipids, destabilizing phos-
pholipids vesicles and promoting processes of aggregation,
fusion and leakage both at neutral and acidic pHs. Fluorescence
depolarization studies show that the three E2 peptides reduce the
DMPG transition amplitude without affecting the transition
temperature. This effect is characteristic of integral membrane
proteins [35], suggesting that these peptides are able to insert
into the membrane interacting hydrophobically with the hydro-
carbon core and restricting the mobility of the acyl chains. The
fact that lipid mixing and release of contents take place only
when negatively charged phospholipids were used could be
explained if the ionic interaction between the peptides and the
polar head group of the phospholipid promotes the subsequent
insertion into the hydrophobic core. This later step would be
responsible of the destabilization which gives rise to fusion. This
dependence with the polar head group of the phospholipid has
been observed in several fusion proteins and peptides of other
viruses. Thus, the fusion peptides of influenza and Sendai
viruses interact preferably with PC vesicles while the fusion
peptide of VSV shows preference for PS vesicles [21] and the
fusion peptide of Ebola virus require the presence of PI in
the target membrane [36]. Also, studies of the fusion of HIV
and SIV with model membranes show a preference for neg-
atively charged liposomes demonstrating higher fusogenic
activity at acidic pH, although viral entry into the host cell is
pH independent [37]. However, this dependence with the pH
and lipid composition observed in viral fusion peptides or even
with whole viruses does not necessarily have a physiological
significance.
The pH dependence observed in the different assays when
acidic phospholipids were employed could be due to a confor-
mational change induced by acidic pH. However, FTIR showed
that all the peptides maintain their conformation independently
of the pH. The pH dependence may also be explained in terms
of the net charge that the peptides have. Thus, E2430–449 has
charge 0 at pH 7.5 while the charge at pH 5.0 is +2. This
increase would give this peptide the highest pH dependence as
it is observed in virtually all the assays. The effect of pH on the
behavior of E2543–560 and E2603–624 peptides would be smaller,since E2543–560 has a +1 charge at both pHs and E2603–624
increase the positive charge from +2 to +3 when decreasing the
pH from 7.5 to 5.0. Indeed, leakage and lipid mixing results are
similar for both peptides at both pHs. However, the fact that
decreasing the pH resulted in the highest increase in OD360
observed for E2603–624 would indicate that the peptide sequence,
besides the positive charge, also play an essential role in deter-
mining the destabilization effects. On the other hand, E2543–560
peptide did not induce any increase of the optical density at
360 nm although this peptide is as effective as the other two in
terms of promoting lipid mixing and release of contents. The
absence of aggregation could be due to the fragmentation of
previously aggregated and fused vesicles as it has been demon-
strated for other fusion peptides [19].
The three putative fusion peptides would occupy an exposed
location on the three dimensional model which has been
proposed for HCVE2 protein based on fold recognition methods
[33]. The exposed character is also indicated by the fact that
amino acids 430–449 constitute the epitope that binds mono-
clonal antibody mAb 7/16b, amino acids 544–551 take part in
the binding of monoclonal antibody mAb 6/53 and residues
623–625 contain the sequence N-X-Twhich can be glycosylated
in the native structure [33]. Moreover, the three peptides have
features characteristic of fusogenic peptides. Thus, they are short
(between 16 and 26 residues) and hydrophobic sequences [38],
E2430–449 and E2543–560 are rich in Gly, Ala and Phe residues
[38], E2430–449 contain the tripeptide GLF which is highly
conserved among the fusion peptides of class I proteins [39]. The
peptide E2603–624 is rich in aromatic residues, a pattern
reminiscent of pre-transmembrane regions in retroviruses and
filoviruses.
Another feature of many internal fusion peptides is a proline at
or near their centers which could mediate the loop structure which
is thought to insert into the lipid bilayer [40–42]. On the other
hand, several evidences suggest that the internal fusion peptide of
ASLVexists as a loop that is stabilized by a disulfide bond at its
base and that this stabilized loop serves an important function
during virus–cell fusion [43]. Also, the structure of the tick-borne
encephalitis virus envelope protein (TBE-E) solved by X-ray
crystallography shows that in its native prefusogenic state the
fusion peptide conforms aβ-strand-turn-β-strand motif stabilized
by disulfide bonds, although in this case there is not any proline
residue [44]. From the FTIR studies, it can be concluded that the
E2 peptides in the absence of vesicles form predominantly
aggregates with an extended β-structure. Moreover, the fact that
infrared spectra were hardly modified by the presence of PG
vesicles suggests that E2 putative fusion peptides interact with
lipids mostly in an extended conformation, compatible with a
β-strand-turn-β-strandmotif. Peptide E2603–624 also contains two
cysteine residues near its ends and a central proline suggesting
that in the E2 protein this region could indeed adopt a loop
structure. Furthermore, this region is highly conserved between
the different variants ofHCV. The involvement of E2430–449 in the
fusion process would be indicated by the fact that monoclonal
antibodies against amino acids 412–447 of E2 neutralize the
infectivity of HIV pseudotypes bearing native hepatitis C virus
glycoproteins [45]. Thus, all these observations taken together
762 B. Pacheco et al. / Biochimica et Biophysica Acta 1758 (2006) 755–763would point to the direct participation of these regions in the
fusion between the viral and cellular membranes. It is difficult to
think of the fusion process between the viral and cellular mem-
branes with only a small region of the envelope protein carrying
the membrane destabilization, since this is a complex process that
requires the approach between two membranes and involves
several biochemical and biophysical interactions. In fact, the
existence of two fusion peptides (oneN-terminal and one internal)
in the envelope proteins of measles, Sendai and HIV-1 viruses has
been described [28,46,47].
In conclusion, the three peptides of E2 studied in this work
induce, although to a different extent, and both at neutral and
acidic pH, close apposition of membranes and destabilization of
acidic phospholipids vesicles, the essential steps required for
fusion [48]. Taken together, our results point out to the involve-
ment of these three regions in the fusionmechanism ofHCVat the
plasma membrane level. The effect of point mutations introduced
in these regions in the membrane destabilizing properties of the
complete E2 protein could offer a better understanding of the early
steps in the infective cycle of HCV.
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